Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
QUESTLAB

Quest Laboratories Share Price

 
Stock touched 52W high

 

Quest Laboratories live price: ₹151.65. It opened at ₹146 vs previous close ₹145; intraday high/low: ₹153/₹142. The 50 & 200 DMA stand at ₹116.62/₹106.99.

Quest Laboratories Performance

  • Today's Low
  • ₹142
  • Today's High
  • ₹153
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹153
  • Open Price₹146
  • Previous Close₹145
  • Volume264,000
  • 50 DMA₹116.62
  • 100 DMA₹110.67
  • 200 DMA₹106.99

Quest Laboratories Chart

Investment Returns

  • Over 1 Month + 48.17%
  • Over 3 Month + 48.68%
  • Over 6 Month + 70.11%
  • Over 1 Year + 38.11%

Smart Investing Starts Here Start SIP with Quest Laboratories for Steady Growth!

Invest Now

Quest Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 18.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 249
  • P/B Ratio
  • 2.6
  • Average True Range
  • 5.95
  • EPS
  • 8.59
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.34
  • RSI
  • 75.3
  • MFI
  • 91.48

Quest Laboratories Financials

Quest Laboratories Technicals

EMA & SMA

Current Price
₹151.65
+ 6.3 (4.33%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹124.38
  • 50 Day
  • ₹116.62
  • 100 Day
  • ₹110.67
  • 200 Day
  • ₹106.99

Resistance and Support

148.75 Pivot Speed
  • R3 166.10
  • R2 159.35
  • R1 155.50
  • S1 144.90
  • S2 138.15
  • S3 134.30

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Quest Laboratories Ltd has an operating revenue of Rs. 125.87 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 18% is great, ROE of 16% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 28% and 49% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 18% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 58 indicates it belongs to a fair industry group of Medical-Biomed/Biotech and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Quest Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results
2025-11-13 Quarterly Results & Others To consider other business matters.
2025-05-28 Audited Results
2025-01-27 Others To consider other business matters.
2024-11-14 Quarterly Results & Others To consider other business matters.

Quest Laboratories Shareholding Pattern

66.78%
0%
0.61%
26.99%
5.62%

Quest Laboratories FAQs

Quest Laboratories share price is ₹151 As on 02 May, 2026 | 20:37

The Market Cap of Quest Laboratories is ₹248.5 Cr As on 02 May, 2026 | 20:37

The P/E ratio of Quest Laboratories is 18.3 As on 02 May, 2026 | 20:37

The PB ratio of Quest Laboratories is 2.6 As on 02 May, 2026 | 20:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23